MARGARET WERBER: Open Payments
NPI 1285387084 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 44 payments from 24 companies in 2025. Trend: 2023 $550 · 2024 $1,347 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $281 |
| Ferring Pharmaceuticals Inc. | 4 | $94 |
| Sumitomo Pharma America, Inc. | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| BIOPROTECT MEDICAL, INC. | 1 | $72 |
| TOLMAR, INC. | 2 | $61 |
| Olympus America Inc. | 3 | $56 |
| UROGEN PHARMA, INC. | 2 | $54 |
| Verity Pharmaceuticals Inc. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $39 |
Products named: ERLEADA, RYBREVANT, ADSTILADRIN, PLUVICTO, BIOPROTECT BALLOON IMPLANT SYSTEM, Xtandi, JATENZO, GEMTESA.
Industry payments across SC — which companies pay providers there.
